Oncotrail RGCC
Oncotrail RGCC provides crucial information on the presence of circulating tumour cells (CTCs) and their concentration in patients who have a confirmed diagnosis of specific forms of cancer, including breast, colon and prostate cancer.
During the test, a sample of blood is analysed to identify the presence and concentration of CTC and their immunophenotype.
Oncotrail RGCC isn’t used as a primary diagnostic test to confirm a cancer diagnosis, but provides essential information on the effectiveness of current cancer treatments. Follow-up tests can also be used to monitor a patient’s health and assess the risk of relapse.
Purpose of the test
Purpose of the test
Oncotrail RGCC provides highly accurate information on the likelihood of existing cancers returning (relapse).
Circulating tumour cells (CTCs) are cells that have detached from the primary tumour and entered the bloodstream. Using a technique called flow cytometry, scientists can search for these cells (or biomarkers) in a blood sample.
Scientists analyse a blood sample to identify whether CTCs exist and in what concentration. This provides an accurate picture of the spread and severity of cancer and its potential for relapse.
Evidence has shown that flow-cytometry testing is highly accurate, and the method has been assessed for sensitivity.
Useful information
Useful information
Oncotrail RGCC tests are currently available for the following types of cancer:
- Breast
- Colon
- GI
- Lung
- Melanoma
- Prostate
- Sarcoma
Oncotrail RGCC requires 7 to 10 ml of whole (peripheral) blood. Once returned to the laboratory, scientists will analyse the sample to identify the prevalence of specific CTCs.
The results, which will need to be interpreted by a clinician, provide a snapshot into whether how successful cancer treatment is, and the likelihood of cancer returning in the future.
Support and training
Support and training
At RGCC, we provide ongoing training and support for clinicians on how to conduct tests and interpret the results for patients. If you would like more information on the Oncotrail RGCC test or any of the advanced diagnostic tests RGCC offers, then get in touch today.